Talia Puzantian, principal investigator, was awarded $25,000 from California Health Care Foundation for “Pharmacy Academic Detailing on Naloxone for Opioid Safety: California Prescription Drug Overdose Prevention Initiative.”
Purdue University
Grants
Eric L. Barker received $650,064 from Defense Advanced Research Projects Agency for “Analytic-Directed Multi-Scale Synthesis System.”
Stephen R. Byrn received $329,635 from National Institute for Pharmaceutical Technology and Education for “Quality Scorecard Analytics Sub-Team.”
Noll L. Campbell received $80,099 from Indiana University for “Brain Health Patient Safety Learning Laboratory.”
Vincent Jo Davisson received $40,000 from Pharmaceutical Research and Manufacturers of America PhRMA Foundation for “Method for Identifying Synthetic Lethal Combinations of Pre-Existing Therapeutics in a Cancer Context.”
Arun K Ghosh received $109,314 from Kumamoto University for “Development of Antiretroviral Agents Such as Non-PIs that Penetrate Central Nervous System and Exert Potent Activity Against Various HIV-1.”
Gregory H. Hockerman received $166,604 from PHS-NIH National Institute Neurological Disorders and Stroke for “Differential Modulation of Cavl.2 and Cavl. 3.”
Casey J. Krusemark received $166,604 from PHS-NIH National Institute Neurological Disorders and Stroke for “Differential Modulation of Cavl.2 and Cavl. 3.”
Seung-Oe Lim received $450,000 from Susan G. Komen Breast Cancer Foundation for “A Novel Strategy of Immunotherapy by Targeting Glycosylation of PD-L1.”
Michael D. Murray received $20,339 from Regenstrief Institute for Health Care for “Observational Medical Outcomes Partnership (OMOP) 2011 Research Collaborations.”
Brian R. Overholser and Tyler A. Shugg received $10,000 from Academic Pharmaceuticals, Inc., for “Herg Inhibition with Sotalol Derivatives.”
Sonak D. Pastakia received $22,429 from University of Warwick for “Ethnic Specific Risk Stratification in Early Pregnancy for Identifying Mothers at Risk of Gestational Diabetes Mellitus in India and Kenya.”
Robert V. Stahelin received $78,169 from National Institute of Health for “Investigation of Vp40 Mutations Found in Previous Outbreaks on the Assembly and Budding of Filoviruses.” Stahelin also received $313,525 from National Institutes for Health for “Lipid-Protein Interactions in Viral Assembly and Virus Like Particle Formation.”
Dan N. Tran and Sonak D. Pastakia received $89,398 from Vanderbilt University for Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor).”
Alan J. Zillich received $80,099 from Indiana University for “Brain Health Patient Safety Learning Laboratory.”
University of Houston
Appointments/Elections
Ronnie Ozuna, clinical assistant professor and assistant dean, Rio Grande Valley Pharm.D. Satellite Program
Jiang-Jiang Qin, senior research scientist
J. Douglas Thornton, assistant professor
Alexa Vyain, clinical assistant professor
Wei Wang, research associate professor
Evan J. Zasowski, clinical assistant professor
Ruiwen Zhang, Robert L. Boblitt Professor of Drug Discovery and professor of Pharmacology and Toxicology
Awards
Richard A. Bond was named Honorary Fellow of the British Pharmacological Society.
Amelia K. Sofjan graduated from the American College of Clinical Pharmacy’s Teaching and Learning Academy.
Divya A. Varkey has been honored with the Texas Society of Health System Pharmacists’ 2017 Special Recognition Award for Educational Service.
Matthew A. Wanat has been inducted as a fellow of the American College of Critical Care Medicine.
Grants
Nicholas D. Beyda received the Society of Infectious Diseases Pharmacists’ Young Investigator Research Award and $20,000 in funding for his project, “Uncovering Novel Mechanisms Governing Non-FKS Mediated Echinocandin Resistance in C. glabrata”
Kevin W. Garey has been awarded a $203,785 grant from the Texas Medical Center’s Health Policy Institute for his project, “Surveillance of Multidrug-Resistant Emerging Healthcare Pathogens”; a one-year, $112,875 award for “Relationships Between Metronidazole Resistance, Pharmacodynamics and Treatment Outcomes in Clostridium difficile Infection” from Texas A&M University Health Science Center; a two-year $247,200 award for “Ultrasensitive C.difficile Toxin Measurement for Diagnosis and Outcome Prediction” from Beth Israel Deaconess Medical Center; and a $98,246 grant from Summit Pharmaceuticals for “Effect of ridinilazole on Clostridium difficile spores.”
Bradley K. McConnell has been awarded a three-year, $475,000 grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation for his project, “Gravin Signalosome is a Novel Therapeutic Drug Target for the Treatment of Heart Failure.”
Vincent H. Tam has been awarded a $546,707 grant from ScPharmaceuticals for his project, “Development and Validation of Tissue Necrosis Animal Models to Test Novel Subcutaneous Formulations.”
Evan J. Zasowski has been awarded the Society of Infectious Diseases Pharmacists/BioMérieux Microbial Diagnostics in Antimicrobial Stewardship and $20,000 in funding for his project, “The Gut is the Source of Multidrug-Resistant Organisms: Diagnostic Development Using Shotgun Whole Genome Sequencing.”
Promotions
Susan M. Abughosh, associate professor
Gregory D. Cuny, associate professor
Samina Salim, associate professor
University of North Carolina at Chapel Hill
Awards
Stefanie Ferreri, American Pharmacists Association 2018 Distinguished Achievement Award in Pharmacy Practice
Alexander “Sasha” Kabanov, Fellow of the National Academy of Inventors
Kamakshi Rao, American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Lifetime Achievement Award
Betsy Sleath, APhA-APRS 2018 Research Achievement Award
David Steeb, APhA 2018 Distinguished New Practitioner Award
Paul Watkins, 2018 American Society for Pharmacology and Experimental Therapeutics Division for Toxicology Career Award
Promotions
Stacy Cooper Bailey, associate professor
Gang Fang, associate professor
Adam Persky, clinical professor
Nicole Pinelli Reitter, clinical associate professor
Grants
Lori Armistead, Community Care of North Carolina, $29,355, Year 3 PTN Support: Statement of Work - Transforming Clinical Practice Initiative: Pharmacy Contributions
Yanguang Cao, NIH National Institute of General Medical Sciences, $47,539, Optimizing antibody-based therapy through a system platform of pharmacokinetics, pharmacodynamics and immunodynamics
Delesha Carpenter, VitalFlo, Inc., $15,000, VitalFlo Formative Study
Mackenzie Cottrell, Chimerix, Inc., $11,610, Work Order 3_Evaluation of sulfolane and 3-nitrobenzyl alcohol on signal for CMX048 and Evaluation of sensitivity and linearity of CMX048 in PBMC lysate
Julie Dumond, University of California at San Francisco, $3,572, Epigenomics of ethnic and racial disparities in ARV exposure and treatment outcomes
Jon Easter, National Association of Chain Drug Stores Foundation, $29,000, Expanding Clinical Services in the Community Pharmacy Setting to Improve Quality and Lower Health-Care Costs
Stephen Frye, NIH National Cancer Institute, $223,654, Modulating the DNA methylation program through UHRF1 antagonism
Daniel Gonzalez, NIH National Institute of Child Health and Human Development, $25,000, Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals
Leaf Huang, ZY Therapeutics, Inc., $10,000, The Development of Novel Taxane Drug Formulation
Robert Hubal, BioMojo, LLC, $41,146, SBIR: beFIT for adaptive physical training
Alexander Kabanov, NIH National Cancer Institute, $310,094, PEGylated Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
Angela Kashuba, NIH National Institute of Allergy and Infectious Diseases, $1,009,409, Novel mass spectrometry imaging methods to quantify antiretroviral adherence
David Lawrence, NIH National Cancer Institute, $451,931, Single cell sampling of signaling activity in triple negative breast cancer
Juan Li, Bamboo Therapeutics Inc., $83,123, Assays and methodology validation for AAV9-hCK-opti-delta-3978 gene therapy vector detection and gene expression
Jian Liu, Pharmaceutical Research and Manufacturers of America Foundation, $40,000, KATELYN ARNOLD Targeting Sterile Inflammation with Sulfated Carbohydrates
Merrie Mosedale, SciKon Innovation Inc., $150,985, SBIR: Standardization of a fluidic in vitro exposure system for IVIVE predictive toxicity data
Philip Smith, University of Colorado Denver, $10,000, Targeted Quantitative Proteomics Analysis of Transporters, CYPs, UGTs in FFPE samples and other tissues.
